These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3856415)

  • 21. [McArdle's disease without typical symptoms].
    Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. McArdle's disease: biochemical and molecular genetic studies.
    Servidei S; Shanske S; Zeviani M; Lebo R; Fletterick R; DiMauro S
    Ann Neurol; 1988 Dec; 24(6):774-81. PubMed ID: 3207360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low muscle levels of pyridoxine in McArdle's syndrome.
    Haller RG; Dempsey WB; Feit H; Cook JD; Knochel JP
    Am J Med; 1983 Feb; 74(2):217-20. PubMed ID: 6572033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucose metabolism during muscular exercise in McArdle's disease].
    Krzentowski G; Pallikarakis N; Pirnay F
    Acta Clin Belg; 1979; 34(3):151-7. PubMed ID: 292291
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased PFK activity and GLUT4 protein content in McArdle's disease.
    Robertshaw HA; Raha S; Kaczor JJ; Tarnopolsky MA
    Muscle Nerve; 2008 Apr; 37(4):431-7. PubMed ID: 18067156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic and circulatory responses to muscular exercise in a subject with glycogen storage disease (McArdle's Disease).
    Andersen KL; Lund-Johansen P; Clausen G
    Scand J Clin Lab Invest; 1969 Sep; 24(2):105-13. PubMed ID: 5269002
    [No Abstract]   [Full Text] [Related]  

  • 27. Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
    Byard RW; Lach B; Preston DN
    Pathology; 1991 Jan; 23(1):62-5. PubMed ID: 2062570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise and recovery ventilatory and VO2 responses of patients with McArdle's disease.
    Hagberg JM; King DS; Rogers MA; Montain SJ; Jilka SM; Kohrt WM; Heller SL
    J Appl Physiol (1985); 1990 Apr; 68(4):1393-8. PubMed ID: 2347781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic exercise test: failure to detect partial expression of McArdle's disease.
    Taylor RG; Lieberman JS; Portwood MM
    Muscle Nerve; 1987; 10(6):546-51. PubMed ID: 3476851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
    Bertorini TE; Shively V; Taylor B; Palmieri GM; Fox IH
    Neurology; 1985 Sep; 35(9):1355-7. PubMed ID: 3860749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease.
    Sahlin K; Areskog NH; Haller RG; Henriksson KG; Jorfeldt L; Lewis SF
    J Appl Physiol (1985); 1990 Oct; 69(4):1231-5. PubMed ID: 2262440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depot-glucagon in the treatment of McArdle's disease.
    Day TJ; Mastaglia FL
    Aust N Z J Med; 1985 Dec; 15(6):748-50. PubMed ID: 3869441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease.
    De Stefano N; Argov Z; Matthews PM; Karpati G; Arnold DL
    Muscle Nerve; 1996 Jun; 19(6):764-9. PubMed ID: 8609928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
    Vissing J; Vissing SF; MacLean DA; Saltin B; Quistorff B; Haller RG
    J Clin Invest; 1998 Apr; 101(8):1654-60. PubMed ID: 9541495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
    Daegelen D; Munnich A; Levin MJ; Girault A; Goasguen J; Kahn A; Dreyfus JC
    Ann Hum Genet; 1983 May; 47(2):107-15. PubMed ID: 6576726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [McArdle disease: differential diagnosis of the increase in creatine kinase induced by the exercise test].
    Frick E; Reutter FW; Weder B
    Schweiz Med Wochenschr; 1988 Dec; 118(52):1993-6. PubMed ID: 3217781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising.
    Perez M; Martin MA; Rubio JC; Maté-Muñoz JL; Gómez-Gallego F; Foster C; Andreu AL; Arenas J; Lucia A; Fleck SJ
    Br J Sports Med; 2006 Aug; 40(8):725-6; discussion 726. PubMed ID: 16864568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. McArdle's disease presenting as treatment resistant polymyositis.
    Higgs JB; Blaivas M; Albers JW
    J Rheumatol; 1989 Dec; 16(12):1588-91. PubMed ID: 2625691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle's disease.
    Lucia A; Gómez-Gallego F; Santiago C; Pérez M; Maté-Muñoz JL; Chamorro-Viña C; Nogales-Gadea G; Foster C; Rubio JC; Andreu AL; Martín MA; Arenas J
    Neuromuscul Disord; 2007 Aug; 17(8):603-10. PubMed ID: 17560787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myophosphorylase B deficiency and malignant hyperthermia.
    Isaacs H; Badenhorst ME; Du Sautoy C
    Muscle Nerve; 1989 Mar; 12(3):203-5. PubMed ID: 2498654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.